SkyQuest projects that the Vaccines market will attain a value of USD 99.85 billion by 2031, with a CAGR of 3.70% over the forecast period (2024-2031). Surging prevalence of chronic diseases and ...
A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac Biotech and immune thrombotic thrombocytopenic purpura ...
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...
Realities of a 'new frontier' of conflict and changing battlefields have forced the Philippines to retool its defence ...
This report presents two cases of TTP occurring after the administration of the inactivated vaccine CoronaVac from Sinovac ...
Tetanus is a serious bacterial infection caused by Clostridium tetani, which affects the nervous system, leading to muscle stiffness and spasms. With an increased awareness of disease prevention, ...
Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy vaccine in the third quarter, dampening overall sales growth. Sales of the jab for respiratory syncytial virus (RSV ...
In 2021, Kennedy told The Associated Press that a similar claim was “misinformation,” and while he was a part of more than 30 lawsuits about vaccine safety, none had appeared before the ...
The outlet noted that the agency implemented a COVID-19 vaccine requirement in October of 2021 during the COVID-19 pandemic. Anyone who requested exceptions from the requirement was fired, according ...
Two new COVID-19 vaccines targeting the KP. 2 variant of the virus have been made available for all Ontarians starting Monday, after weeks of only being open to high-risk and priority populations ...